Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-01-03 @ 11:05 PM
Study NCT ID:
NCT03226756
Status:
COMPLETED
Last Update Posted:
2023-01-18
First Post:
2017-07-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab in Recurrent and/or Metastatic SCCHN
Sponsor:
UNICANCER
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-31
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-04
First Submit QC Date:
None
Study First Post Date:
2017-07-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-17
Last Update Post Date:
2023-01-18
Last Update Post Date Type:
ACTUAL